Yuzhi Wang Selected Research

jianpi yishen

1/2022

A Chinese Medicine Compound Alleviates Cisplatin-Induced Acute Kidney Injury via Its Antiapoptosis and Anti-Inflammation Effects in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuzhi Wang Research Topics

Disease

12	Neoplasms (Cancer) 02/2022 - 02/2015
7	Breast Neoplasms (Breast Cancer) 10/2020 - 09/2014
5	Carcinogenesis 01/2022 - 10/2015
3	Chronic Renal Insufficiency 01/2022 - 10/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 10/2015
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2022
1	Stomach Neoplasms (Stomach Cancer) 02/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Non-alcoholic Fatty Liver Disease 10/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Triple Negative Breast Neoplasms 01/2019
1	Carcinoma (Carcinomatosis) 01/2018
1	Lymphatic Metastasis 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Pre-Eclampsia (Preeclampsia) 07/2017
1	Ovarian Epithelial Carcinoma 01/2016
1	Allergic Rhinitis 01/2015

Drug/Important Bio-Agent (IBA)

3	RNA (Ribonucleic Acid)IBA 02/2022 - 10/2020
3	CarcinogensIBA 01/2022 - 10/2015
2	SmokeIBA 05/2022 - 01/2022
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
2	Perindopril FDA LinkGeneric 01/2022 - 10/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	Long Noncoding RNAIBA 10/2020 - 01/2018
2	Biological ProductsIBA 01/2020 - 01/2016
2	Estrogen ReceptorsIBA 01/2019 - 01/2018
2	GATA Transcription FactorsIBA 12/2018 - 01/2018
2	Phenobarbital (Luminal)FDA Link 01/2018 - 09/2014
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 02/2022
1	DNA AdductsIBA 01/2022
1	Huang QiIBA 01/2022
1	4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butan- 1- olIBA 01/2022
1	7,8-dihydromethysticinIBA 01/2022
1	jianpi yishenIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Adenine FDA LinkGeneric 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	KetonesIBA 01/2022
1	Nicotine FDA Link 01/2022
1	NitrosaminesIBA 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	PhytochemicalsIBA 01/2022
1	EpitopesIBA 12/2021
1	sarkosylIBA 12/2021
1	Sirtuin 3IBA 10/2021
1	AntioxidantsIBA 10/2021
1	LipidsIBA 10/2021
1	porphyceneIBA 01/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021
1	SulfonamidesIBA 01/2021
1	hydroxide ionIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	Amyloid beta-PeptidesIBA 01/2020
1	CRT 0066101IBA 01/2019
1	Propidium (Propidium Iodide)IBA 01/2019
1	Protein Kinase D2IBA 01/2019
1	Annexin A5IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	protein kinase DIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	SOX Transcription FactorsIBA 11/2018
1	Untranslated RNA (Noncoding RNA)IBA 01/2018
1	UbiquitinIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Histone Deacetylase 2IBA 01/2018
1	Histones (Histone)IBA 01/2018
1	Ubiquitin-Specific ProteasesIBA 01/2018
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 07/2017
1	protein kinase C nuIBA 01/2017
1	AndrogensIBA 01/2016
1	Androgen Receptors (Androgen Receptor)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 10/2015
1	Glycoproteins (Glycoprotein)IBA 02/2015

Therapy/Procedure

5	Therapeutics 01/2022 - 02/2015
2	Immunotherapy 01/2022 - 01/2015
1	Drug Therapy (Chemotherapy) 01/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022
1	Chemoprevention 01/2022
1	Photochemotherapy (Photodynamic Therapy) 01/2021